Back to Journals » OncoTargets and Therapy » Volume 12
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
miR-4262, low level of which predicts poor prognosis, targets proto-oncogene CD163 to suppress cell proliferation and invasion in gastric cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
5,316 | Dovepress* | 5,031+ | 801 | 5,832 | |
PubMed Central* | 285 | 102 | 387 | ||
Totals | 5,316 | 903 | 6,219 | ||
*Since 15 January 2019 |
View citations on PubMed Central and Google Scholar